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The Overall Pattern of Cardiac Contraction
Depends on a Spatial Gradient
of Myosin Regulatory Light Chain Phosphorylation
1984; Beyar and Sideman, 1986). It has been previously
observed, but not fully understood, that the epicardial
fibers dominate the endocardial fibers (Buchalter et al.,
1990; Maier et al., 1992; Young et al., 1994). That is,
despite the counter-helical orientation of the endocar-
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dial fibers, the full thickness of the wall moves with theCardiology Branch
epicardial twist.National Heart, Lung, and Blood Institute
At the molecular level, the contraction of cardiac mus-National Institutes of Health
cle is driven by isoforms of myosin molecules that hy-Bethesda, Maryland 20892
drolyze ATP, providing energy to move interdigitating2 Laboratory of Cardiac Energetics
thick myosin filaments past actin-containing thin fila-National Heart, Lung, and Blood Institute
ments. Myosin heads constitute the crossbridges thatNational Institutes of Health
extend outward from the thick filament backbones andBethesda, Maryland 20892
repetitively bind to, move, and detach from sites on the
actin-containing thin filament. The myosin heads taper
to an -helical neck that connects the head to the rodSummary
region. The rod is responsible for the self-assembly of
the myosin molecules into the thick filaments. TheEvolution of the human heart has incorporated a vari-
-helical myosin neck region is supported by two dumb-ety of successful strategies for motion used through-
bell-shaped molecules. These molecules are the essen-out the animal kingdom. One such strategy is to add
tial light chains (ELC) and regulatory light chains (RLC).the efficiency of torsion to compression so that blood
Clusters of mutations throughout the human cardiacis wrung, as well as pumped, out of the heart. Models
myosin head cause hypertrophic cardiomyopathy (Ray-of cardiac torsion have assumed uniform contractile
ment et al., 1995). The myosin head mutations haveproperties of muscle fibers throughout the heart. Here,
been used to show that slow skeletal muscle expresseswe show how a spatial gradient of myosin light chain
-cardiac myosin (Cuda et al., 1993). This finding hasphosphorylation across the heart facilitates torsion by
allowed functional and structural studies of the mutantinversely altering tension production and the stretch
cardiac myosins from HCM patients to be performed onactivation response. To demonstrate the importance
slow skeletal muscle biopsies from these patients (Cudaof cardiac light chain phosphorylation, we cloned a
et al., 1993; Lankford et al., 1995; Levine et al., 1998).myosin light chain kinase from a human heart and
Phosphorylation of the RLC in smooth muscle andhave identified a gain-in-function mutation in two indi-
nonmuscle myosins controls the activation of the myo-viduals with cardiac hypertrophy.
sin ATPase (Bresnick, 1999). RLC phosphorylation of
skeletal/cardiac muscle myosins, however, has only
Introduction been shown to produce a modest increase in tension
and an increase in Ca2 sensitivity at submaximal levels
The efficient contraction of the heart utilizes both a com- of Ca2 activation (reviewed by Sweeney et al., 1993).
pressing and wringing motion to eject blood from the Thus, the major control of tension in these muscles is
ventricles. This wringing motion, or torsion, is a striking at the level of the thin filament, through the binding of
aspect of the beating heart when viewed in a surgically Ca2 to the troponin-tropomyosin complex. Electrical
opened chest. Torsion depends, in part, on the helical stimulation increases the level of Ca2 bound to tropo-
orientation of the cardiac myofibers that spiral in a left- nin-tropomyosin, allowing actin and myosin to interact
handed helix from the tip (apex) to the top (base) of the and generate force. Recently, we have shown that the
heart at the epicardial surface. On the inner (endocardial) tension increase associated with RLC phosphorylation
surface of the ventricles, the fibers have a counter right- is accompanied by a change in a property called stretch
handed helical orientation (Streeter et al., 1969; Green- activation (J.D. et al., submitted).
baum et al., 1981). Our hands mimic these orientations The stretch activation response is an intrinsic property
when wringing an object, with the fingers on the left and of unknown physiologic significance in most muscles.
right hands forming the respective helical directions, It is exaggerated in the indirect flight muscle (IFM) of flies
and the thumbs denoting the upward spiral. Beyond the and, as such, is responsible for the oscillatory power
increased efficiency provided by torsion, the two distinct required for flight. It has been previously conjectured
helical orientations of the fibers are believed to help to be important to the vertebrate heart (Pringle, 1978;
Steiger, 1977). Indeed, the use of the word “beating”equalize stress and strain throughout the heart. Models
to describe the movement of wings, as well as the heart,of this equalization have all assumed uniform mechani-
reflects the fact that both use oscillatory power. Mutantcal properties of fibers across the heart (Arts et al.,
Drosophila expressing a nonphosphorylated myosin
RLC in the IFM lose the stretch activation response;3 Correspondence: nepstein@helix.nih.gov
although their IFM produces normal isometric tension,4 These authors contributed equally to this work.
their oscillatory power is decreased and these flies are5 Present address: Scientific Review Office, National Institute on
Aging, National Institutes of Health, Bethesda, Maryland 20892. flightless (Tohtong et al., 1995).
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Mutations in both the ELC and RLC cause a rare form
of midcavity HCM (Poetter et al., 1996). This variant
morphology is characterized by hypertrophied papillary
and adjacent ventricular muscle with little or no effect on
the apex of the heart. Papillary muscles from transgenic
mice expressing a patient’s mutant ELC show a dramatic
change in the stretch activation response long before
they develop any observable hypertrophy (Vemuri et
al., 1999). Because the mutant ELC gene is uniformly
distributed throughout the ventricles, the pattern of mid-
ventricular hypertrophy identifies the parts of the heart
that most depend on the stretch activation response.
When deprived of it, these parts develop a compensa-
tory hypertrophy. The human mutations surrounding the
site of RLC phosphorylation are associated with the
same rare midcavity hypertrophy as hearts of patients
and mice with the ELC mutation. In contrast to the rare
event of a myosin light chain mutation, normal hearts
produce a continuous turnover of RLC phosphorylation.
Thus, modulation of stretch activation through RLC
phosphorylation could have important consequences to
normal cardiac physiology.
We now present evidence that the complex muscle me-
chanics of the beating heart are facilitated by a spatial
gradient from high (epicardial) to low (endocardial) levels
of phosphorylated myosin RLC that is matched by levels
of a myosin light chain kinase (MLCK) we have cloned
from human heart. Mechanical studies of single slow mus-
cle fibers show that this spatial gradient of RLC phos-
phorylation will increase tension, decrease the stretch
activation response of the epicardial fibers, and produce
the converse effect in the endocardium. The different
muscle mechanics across the ventricular wall support
Figure 1. Western Blot Showing Specificities of HuRLCP andcardiac torsion and help explain the pattern of cardiac
MuRLCP Antibodiescontraction viewed with magnetic resonance imaging.
(A) Western blot with HuRLCP antibody. Expressed human RLCThe importance of this property to cardiac function is
without () (lane 1) and with () (lane 2) kinase. RLC/ELC complexhighlighted by the report of a gain-in-function MLCK
(human -myosin light chain binding region, ELC, and RLC) withoutmutation in two individuals with cardiac hypertrophy.
(lane 3) and with (lane 4) kinase. Myosin extracted from human heart
(lane 5) and with added kinase (lane 6). Mouse heart homogenate
Results (lane 7). Coomassie blue stain of protein loading is shown below
each lane.
(B) Fresh-frozen murine heart stained with MuRLCP antibody. De-Distribution of Phosphorylated RLC in Heart
tection of RLCP in thick filaments (B1) is reversed by PP1 phospha-In order to study the in vivo effect of phosphorylated
tase treatment (B2).
cardiac myosin RLC, a polyclonal antibody was raised (C) Western blot with MuRLCP antibody. Mouse heart homogenate
against a peptide containing the RLC-phosphorylated (lane 1). Expressed human RLC without (lane 2) and with (lane 3)
serine with the three flanking residues on either side. kinase. Extracted human cardiac myosin without (lane 4) and with
(lane 5) kinase showing a baseline level of phosphorylation in ex-After an initial attempt to raise a useable antibody failed,
tracted human cardiac myosin that is increased upon treatment withinoculation with a concatamer of two such peptides
kinase. Phosphorylated RLC detection (lane 6) is reversed by PP1produced specific antibodies. Two polyclonals were
phosphatase treatment (lane 7).
made, one against human (huRLCP) and another against
murine (muRLCP) sequence. On Western blot, both anti-
bodies detected only the phosphorylated human car-
diac RLC. The specificity of these antibodies hold for tection by this antibody is reversed by treatment with a
serine/threonine phosphatase, PP1 (Upstate), in botheither the expressed RLC alone or the RLC/ELC com-
plex, which is the human ventricular RLC and ELC bound fresh-frozen murine cardiac tissue samples and Western
blot analysis of phosphorylated expressed human RLCto the human -myosin heavy chain light chain binding
region (aa 778–840) as seen in Figures 1A and 1C. By (Figures 1B and 1C).
When used to stain a sample of normal human cardiacWestern blot analysis, both antibodies detected a back-
ground of RLCP in either mouse or human heart that is ventricle, both huRLCP (Figure 2A) and muRLCP (data
not shown) detect phosphorylated myosin thick fila-increased upon the addition of expressed myosin light
chain kinase (Figures 1A and 1C). HuRLCP is specific ments. In order to study the global pattern of phosphory-
lated RLC across the heart, muRLCP was used to stainfor human substrate, while muRLCP reacts with rabbit,
murine, and human substrate (Figures 1A and 1C). De- longitudinal and transverse sections of normal murine
Cardiac Torsion Uses Myosin RLC Phosphorylation
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Figure 2. Gradients of RLC Phosphorylation
in the Heart
(A) HuRLCP antibody staining of the A bands
of two normal human ventricular myocytes.
The absence of staining of the central nucleus
(N) is evident in the larger cell.
(B) Cross-sections of three fibers (arrow de-
notes higher level of RLCP) from highly phos-
phorylated mouse epicardium stained with
muRLCP showing the fiber-to-fiber patchy
distribution of RLC phosphorylation.
(C) Western blot using huRLCP antibody
(lanes 1 and 2) and antibody against total RLC
(lanes 3 and 4). A higher ratio of phosphory-
lated RLC (lane 2) to total RLC (lane 4) is present
in the apex of the human heart compared with
ratio of phosphorylated RLC (lane 1) to total
RLC (lane 3) in mid-left ventricle. Separate
gels for lanes 1 and 2 and lanes 3 and 4 were
loaded with equal amounts of protein.
(D) Similar study using rabbit heart tissue
shows a higher ratio of phosphorylated to
total RLC in apex versus septal tissue. High
molecular weight bands at top of gel are myo-
sin stained with MF-20 antibody.
(E) Ventriculogram of patient with M149V ELC
mutation, showing the constricted hourglass-
shaped left ventricular cavity due to hypertro-
phy of the papillary muscle and adjacent en-
docardium (yellow arrow). The normally open
left ventricular cavity, as pictured in Figure
4C, now excludes dye from the middle of the
cavity leaving two cavities marked with an
asterisk connected by a stenotic passage.
(Adapted from Poetter et al., 1996; reprinted
with permission of Nature Publishing Group
and Dr. Neil Epstein, Nat. Genet., 13, 1996,
pp 63–69.)
(F) Longitudinal section of transgenic mouse heart expressing human M149V ELC mutation. Hypertrophy of the papillary muscle and adjacent
endocardium in the patient’s heart is reproduced in this mouse (yellow arrow). (Adapted from Vemuri et al., 1999; reprinted with permission
of PNAS and Dr. Neil Epstein, Proc. Natl. Acad. Sci. USA, 96, 1999, pp 1048–1053.)
(G) A representative normal mouse heart stained with muRLCP antibody demonstrating hypophosphorylated papillary muscle and adjacent
endocardium (yellow arrow) that corresponds with the hypertrophied region in transgenic mouse (Figure 2F) and patient heart (Figure 2E).
hearts. A nonuniform but reproducible gradient of ex- tients with the same (M149V) mutant ELC (Vemuri et al.,
1999). The midventricular hypertrophy of a patient withpression extends inward from the apex and epicardium
(Figures 2G, 4B3, and 4B4). Western blot analysis with the M149V mutation is evident in a ventriculogram (Fig-
ure 2E). In transgenic mouse hearts expressing the samehuman and rabbit tissue samples from apex and midven-
tricle, stained with muRLCP, confirms this nonuniform mutant ELC (Figure 2F), the dramatic hypertrophy of
the papillary muscles and the adjacent endocardiumpattern of expression across species (Figures 2C and
2D). Within regions of high expression in the heart there produces the hourglass shape of the left ventricular cav-
ity. The comparison shows that the regions of midcavityis significant fiber-to-fiber variation in RLC phosphoryla-
tion (Figure 2B). hypertrophy in patients and transgenic mice correspond
to the hypophosphorylated region in a normal mouse
heart (Figure 2G).Cardiac RLC Phosphorylation Correlates with the
Hypertrophic Pattern in Hearts of Patients
with RLC and ELC Mutations The Effect of RLC Phosphorylation on the Kinetics
of Contraction and Tension in RabbitThe most dramatic aspect of the pattern of RLC phos-
phorylation in the normal human, mouse, and rabbit Skeletal Muscle Fibers
Rabbit and human slow skeletal muscle fibers are opti-hearts is that the region of midcardiac hypertrophy in
patients with either light chain mutations or transgenic mal preparations to study the crossbridge cycle kinetics
of cardiac myosin for the following reasons: (1) Humanmice with the ELC mutation (Poetter et al., 1996)
matches the pattern of RLC hypophosphorylation in the and rabbit slow skeletal muscle fibers express cardiac
myosin (Cuda et al., 1993). (2) The small size of cardiacnormal heart. Although human hearts have not been
available for detailed in situ studies, the 1-year-old trans- muscle cells, their branching architecture, and their
large amount of associated connective tissue make itgenic mice expressing the human mutant ELC repro-
duce the midcavity hypertrophy phenotype of the pa- difficult to obtain reliable mechanical results from single
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lated RLC fibers. Changes in the shape of the tension
transients also occur with phosphorylation and are best
compared in Figure 3B, where they are normalized to
their respective isometric tensions. Here, it is evident that
the trough-to-peak excursion is proportionally greater in
the RLC versus RLCP containing fibers (17% and 10% of
normalized isometric tension, respectively). Relaxation
kinetics studies that impose small step-stretches on
these fibers have shown that the stretch activation re-
sponse (Huxley-Simmons phase 3) is disproportionately
increased in fibers without phosphorylated RLC (J.D. et
al., submitted). Thus, in both large- and small-stretch
studies, the increased tension produced by RLCP is
associated with a reciprocal drop in the stretch activa-
tion response while the converse effect occurs in non-
phosphorylated fibers. These mechanical differences,
associated with the gradient of RLC phosphorylation
across the ventricular wall, help explain how cardiac
torsion is generated.
Cloning of the Human Skeletal Muscle Myosin
Light Chain Kinase from Human Heart
In order to further study the gradient of RLC phosphory-
lation, we cloned an MLCK (MYLK2) from human heart.
Since the first report that cardiac myosin RLC is phos-
phorylated in vivo (Perrie et al., 1972), there has been
an unsuccessful search for the active cardiac kinase(s).
Because cardiac -myosin and its RLC is expressed in
slow skeletal muscle fibers of rabbits and humans, the
skeletal MLCK has been a candidate kinase. Despite
this intuition, the existence of skeletal MLCK in the heartFigure 3. Changes in the Kinetics of Stretch Activation and Fiber
Tension due to Regulatory Light Chain Phosphorylation is controversial (Herring et al., 2000). We reasoned that
A Large step-stretch of 12 nm per half sarcomere was applied to a the active sarcomeric myosin light chain kinase in heart,
single isometrically contracting fiber at time zero (see arrow). Deter- if not actually the skeletal isoform, would likely share
gent-skinned rabbit soleus slow type I fibers were used. Sufficient homology with the catalytic region of the skeletal muscle
Ca2 was added to the activating solution to produce 20% maximal MLCK. For RT-PCR, we designed a set of primers from
tension with RLC-containing fibers at 20C. The inset shows gel analy-
this region of the gene. Fragments of identical sequencesis of segments of the fiber before and after RLC phosphorylation.
that cross an intron-exon boundary were amplified from(A) Note the large increase in the baseline isometric tension (before
stretch at time zero) from RLC phosphorylation. rabbit heart and skeletal muscle RNA. Degenerate ver-
(B) The same data as in Figure 3A, but with the transients normalized sions of these primers were used to amplify the homolo-
to their isometric tension in order to highlight changes in the shape gous fragment from human cardiac RNA. The sequence
caused by RLC phosphorylation. Note the increase in fiber tension from this fragment was used to generate both 3- and
from RLC phosphorylation illustrated in Figure 3A is matched here
5-RACE products. The gap between the two RACEby a reciprocal 41% depression in the delayed rise in tension or
products was closed by RT-PCR amplification of humanstretch activation response.
cardiac RNA. The full-length cDNA obtained in this way
matched the full-length cDNA that we cloned from hu-
man skeletal muscle RNA. The human amino acid se-
quence is 89% homologous to rabbit skeletal MLCK.cardiac cells or ventricular strips. (3) The kinase we
Most of the discordance is in the first 250 residues,cloned from human heart is expressed throughout skele-
before the start of the catalytic region. A P1 genomictal muscle. (4) The stretch activation response was noted
clone containing the full-length human gene was ob-in skeletal muscle before it was described in the heart.
tained by PCR library screening (Genome Systems) us-Therefore, in order to study the effect of RLC phos-
ing an intron-based primer pair derived from the originalphorylation on cardiac mechanics, we evaluated slow
human cardiac RT-PCR fragment. The full-length car-fibers from rabbit soleus muscle. Single skinned fibers
diac MLCK cDNA sequence is embedded in the genomicwere phosphorylated with expressed human skeletal/
P1 clone and all 12 intron-exon boundaries have beencardiac MLCK (see below). Each fiber was subjected to
identified. The P1 clone has been mapped to chromo-large stretches (0.4%–0.8% muscle lengths) before and
some 20q13.3.after RLC phosphorylation. Figure 3A shows the dra-
matic 2-fold increase in isometric tension caused by
RLC phosphorylation. Consequently, the magnitude of The Study of the Skeletal/Cardiac MLCK Pattern
of Distribution in Skeletal and Cardiac Tissuethe tension increase caused by stretch and the ensuing
tension transient is noticeably greater in the phosphory- In order to study the distribution of the MLCK cloned
from human heart, a polyclonal antibody to the entirelated RLC-containing fibers than in the nonphosphory-
Cardiac Torsion Uses Myosin RLC Phosphorylation
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Figure 4. Spatial Distribution of Skeletal/Car-
diac MLCK and Phosphorylated RLC
(A) Immunofluorescent staining of serial sec-
tions of human deltoid muscle with huRLCP
(panel A1) and antibody against human skele-
tal/cardiac MLCK (panel A2), to show colocali-
zation. Parallel studies on serial sections of
rabbit skeletal muscle are shown in (panels
A3 and A4). Arrows mark the same fibers in
serial sections.
(B) Immunofluorescent staining of transverse
slices from mouse heart shows a gradient of
MLCK decreasing from the apex (panel B1) to
the base (panel B2) of the heart. This mirrors
the gradient of phosphorylated RLC (panels
B3 and B4) stained with muRLCP staining.
(C) Artist’s rendition of the heart showing the
regions from which the tissue slices in 4B
(panels 1–4) were taken.
(D) Western blot detection of MLCK in mouse
heart with antibody against the human en-
zyme. Fragments from mouse heart (lanes 2
and 3) run higher than expressed human
MLCK (lane 1). Apical tissue (lane 3) has a
higher MLCK signal compared to interventric-
ular septal tissue (lane 2). A mouse skeletal
muscle tissue control is presented in (lane 4).
Proteolytic bands, common to lanes 2–4, run
at low MW. Protein loading using Coomasie
blue stain is shown at bottom.
(E) Western blot showing fragments detected
by antibody against human MLCK. 74 kDa fragment present in human heart septum (lane 1) and apex (lane 2) matches the fragment
corresponding to skeletal muscle MLCK in lane 3 and expressed human skeletal MLCK in (lane 4). Additional bands running at 98 kDa and
120 kDa are present in lanes 1 and 2. There is an increased concentration of the 98 kDa band in apical tissue (lane 2). Protein loading is
shown at the bottom with an antibody to GAPDH.
human protein was produced. The full-length cDNA en- (Figures 4B3 and 4B4). Western blot analysis of tissue
homogenates from mouse septum and apex are consis-coding the human MLCK protein, with a 5-FLAG-tag
sequence, was expressed in a baculoviral system (Phar- tent with the fluorescent studies (Figure 4D). A sample
from apex and septum of a transplanted human heart,mingen). The FLAG-tag affinity purified protein was used
to inoculate rabbits according to standard protocols. frozen soon after harvest, shows a similar distribution
(Figure 4E). In the human heart, the skeletal/cardiacThe serum from inoculated rabbits was affinity purified
against the full-length protein. This antibody detects the MLCK fragment matching the 74 kDa expressed human
MLCK is observed along with two larger fragments ofexpressed human MLCK and the corresponding frag-
ment in Western blots of human and mouse heart or 98 and 120 kDa (Figure 4E). These larger fragments may
represent additional crossreacting proteins, alterna-skeletal muscle. Immunofluorescent studies on fresh-
frozen samples were also performed. tively spliced isoforms, and/or posttranslational modifi-
cations of the 74 kDa fragment. The 98 kDa fragment isThe MLCK antibody against human skeletal/cardiac
myosin lightchain kinase was initially characterized by consistently of greatest intensity in human apical sam-
ples. This may be the source of increased levels of RLCPstaining serial fresh-frozen sections of normal human
quadriceps tissue. Alternate serial sections probed with at the apex.
huRLCP or anti-MLCK show costaining (Figures 4A1 and
4A2). Similar findings are seen in rabbit skeletal muscle A Mutant Human Skeletal/Cardiac RLC Kinase
with Abnormal Kineticsusing the same anti-MLCK antibody paired with the
muRLCP antibody (Figures 4C3 and 4C4). We reasoned that since mutations in the RLC substrate
of the kinase cause cardiac hypertrophy, MLCK muta-In order to evaluate the presence and distribution of
skeletal/cardiac MLCK in a normal heart, mouse hearts tions might also be found in a population of patients
with cardiac hypertrophy.were flash frozen in cooled isopentane immediately fol-
lowing sacrifice. Serial 20 m thick longitudinal and Intron-exon boundaries established during the clon-
ing were used to generate intron-based primer pairs fortransverse slices from the apex through the midventricu-
lar region were prepared. Samples from a series of nor- PCR amplification for all 12 exons. The MLCK genes
from 490 unrelated patients with cardiac hypertrophymal mice were probed with anti-MLCK antibodies. Immu-
nofluorescent staining consistently showed an increased and 189 normal controls were screened. A portion of
the gene from 500 coronary artery disease patients wasintensity in the apical cross-sections compared to the
midventricular regions (Figures 4B1 and 4B2). Adjacent also screened.
Single strand conformation polymorphism (SSCP) de-serial sections show the correlation with RLCP signals
Cell
636
the mutant MLCK may be functionally abnormal, and
may consequently stimulate cardiac hypertrophy.
Enzyme Kinetics of the Mutant MLCK
In order to further investigate the effect of the mutant
kinase, both full-length wild-type and mutant baculovi-
ral-expressed human skeletal/cardiac MLCK proteins
were used to phosphorylate the RLC/ELC complex. Fig-
ure 5B shows a double reciprocal plot of 1/v versus
1/[S] comparing the mutant and wild-type MLCK. The
mutant MLCK shows a gain in function since the Vmax of
the mutant is almost double that of the wild-type MLCK
(216  31 versus 115  15 pmol min1 ng1, respec-
tively). Although the Km of the mutant is also significantly
greater than the wild-type (17.0  4.6 versus 6.0  1.8
M, respectively), at physiologic concentrations of light
chain (300 M), differences in Vmax dominate the rate
of RLC phosphorylation.
Detailed Investigation of Muscle Strain Pattern
in the Left Ventricle with Noninvasive Phase-
Labeled MRI Techniques (metaDENSE)
We have described a differential pattern of myosin RLC
phosphorylation from epicardium to endocardium across
the ventricular wall. This, together with the biophysical
changes observed in single fiber studies, predicts an
effect on the global pattern of cardiac contraction. In
order to study the pattern of contraction in the normal
human heart, we utilized recent developments in phase-
labeled MRI motion tracking that allow detailed mapping
of muscle strain and torsion distribution in the left ven-
tricular wall (Aletras and Wen, 2001; Callaghan, 1991).
One such technique, metaDENSE, has been optimized
to map the displacement field of the human heart at 2.8
mm resolution during a breath-hold of 14 heartbeats,
over the entire systolic or diastolic period. The spatial
Figure 5. Inheritance, Substrate Site, and Kinetics of the Mutant resolution of this technique is sufficient to clearly show
Human Skeletal/Cardiac MLCK changes in the contractile strain and torsion of the mus-
(A) 3D structure of chicken skeletal muscle myosin S1 showing the cle across the wall. The left ventricle undergoes torsion
homologous site to the inherited human E743D heavy chain mutation around its long axis during systolic contraction; i.e., the
on a short -helix adjacent to the ELC. The approximate position
apex rotates relative to the base. Recoil occurs in theof the MLCK target site (RLC serine 15) is indicated. Inheritance of
diastolic period. The direction of torsion is consistentthe mutations is depicted in the pedigree. ELC is in yellow and RLC
is in magenta. with the helical arrangement of the epicardial muscle
(B) Double reciprocal plot showing gain of function in mutant ex- fibers but counters the helicity of the endocardial fibers.
pressed MLCK (red) compared with expressed wild-type (blue) pro- Therefore, the epicardium is thought to produce the
tein. Vmax and Km of both proteins are shown below. torsion during systole.
High-resolution torsion measurements with metaDENSE
showed 50%–70% increase in normalized torsion from
the epicardial to endocardial border (H.W., unpublished
tection on gels was used for screening. Although a num- data). Figure 6B is a color-coded distribution of the rotation
ber of polymorphisms (to be published in a separate of the myocardial wall around the left ventricle (LV) center
article) were observed, only a single mutation was identi- in a slice of the LV perpendicular to its long axis, about
fied. This is a double point mutation inherited on the one-fourth the LV length from the apex. This distribution
maternal haplotype by a 13-year-old white male proband is derived from a set of metaDENSE images that encode
with early midventricular hypertrophic cardiomyopathy. the wall motion over the entire systolic period. The blue
The MLCK mutations are A87V and A95E. The proband color indicates that the overall rotation is in the left-
also inherited an E743D-myosin mutation from his father. handed counter-helical direction of the epicardial fibers.
Although the son had significant disease at an early age, The endocardium is darker in color than the epicardium,
the father and mother came to medical attention only indicating an increase in the angle of rotation from the
after the diagnosis of the son. Echocardiographic evalu- epicardial border to the endocardial border. This phe-
ation shows that both parents have similarly abnormal nomenon has also been observed with MR tagging stud-
asymmetrically thickened hearts. The kindred (Figure ies at lower spatial resolution (Buchalter et al., 1990;
Maier et al., 1992; Young et al., 1994).5A), being too small for linkage analysis, suggests that
Cardiac Torsion Uses Myosin RLC Phosphorylation
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Figure 6. Cine- and Phase-Tagged MRI Images of the Human Heart
(A) Series of cine-MRI images of the left ventricle taken every 50 ms, showing the stretching of the papillary muscles (posterior papillary
muscle is marked with a “p” during early systole. Frames 1 and 2 are traced to highlight the papillary muscles, and an overlay (3) provides
comparison. The interventricular mitral valve leaflet is labeled with an “m”.
(B) A color-coded map of the gradient of angles of rotation, around the LV center. The slice is perpendicular to the left ventricle, at a distance
of one-fourth the LV length from the apex. Each square pixel in the map represents 55 l of muscle tissue from a volume 2.8 mm 	 2.8
mm 	 7 mm thick. The color range covers angles from 30 to 30. The blue appearance indicates that the overall rotation is in the
counterclockwise, left-handed helical direction. The darker colors of the endocardium represent higher rotation angles compared to the
epicardium.
Changes in Papillary Muscle Anatomy leads to the closing of the interventricular valves. This
in turn stretches the already activated papillary musclesand Movement during Systole Viewed
with Cardiac Cine-MRI by their valvular attachments, the chordae tendineae
(Figure 6A).In order to study the human cardiac papillary muscles,
“cine-MRI” with 50 ms resolution was used to follow
their movement throughout systole (Zur et al., 1990). Discussion
The papillary muscles are among the earliest portions
of the ventricle to be electrically stimulated (Rushmer, This report provides evidence for the existence of a
spatial gradient of myosin RLC phosphorylation in the1956). A series of five frames (Figure 6A), beginning in
cardiac systole, shows that despite the signal to con- heart. We also describe specific changes in the contrac-
tile mechanism of slow muscle fibers powered by car-tract, the papillary muscles are stretched early in systole
while other portions of the ventricle are contracting. The diac -myosin that occur upon RLC phosphorylation.
The differential pattern of phosphorylation and the con-mechanism, apparent in the five frames, involves the
increasing intraventricular pressure in early systole that comitant variation in the mechanical properties of the
Cell
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fibers help explain the details of cardiac contraction that crease in the size of the stretch activation peak, a
change equivalent to 7% of fiber isometric tension.are observed with MRI imaging presented here. These
We previously observed that an ELC mutation causedfindings also help explain why some patients with muta-
the rate of the papillary muscle stretch activation re-tions surrounding the phosphorylatable serine of the
sponse to become too fast to be matched with the mu-RLC have the same rare cardiac phenotype as patients
rine physiologic heart rate (Vemuri et al., 1999). Conse-with a distorted stretch activation response associated
quently, work produced by this response cannot be usedwith a mutant ELC. In order to further investigate the
to increase oscillatory power in the portions of the mu-effects of RLC phosphorylation in the heart, we have
tant heart that would otherwise be able to take advan-also cloned an MLCK from human heart. This MLCK is
tage of this property. Here it is shown that RLC phos-identical to skeletal muscle light chain kinase. Evidence
phorylation leaves the rate unchanged but drops thethat it is active in the heart comes from two findings.
amplitude of the stretch activation response signifi-First, we demonstrated that spatial gradients of the
cantly. This is the possible benefit of maintaining theMLCK protein correspond to the pattern of RLC phos-
papillary muscles and endocardium of normal heart inphorylation. Second, we have identified a gain-in-func-
a state of hypophosphorylation, thereby increasing thetion mutation in the enzyme found in both a mother and
relative amplitude of the stretch activation response ina son with cardiac hypertrophy.
these parts of the heart. For these reasons, mutations
in either light chain burden the papillary muscles and
Myosin RLC Phosphorylation Varies from Fiber adjacent endocardium by distorting the stretch activa-
to Fiber in Skeletal and Cardiac Muscle tion response (either rate or amplitude), leading to a
across Species compensatory hypertrophy of these regions. The nor-
We have generated two polyclonal antibodies that rec- mally high level of RLC phosphorylation at the cardiac
ognize the phosphorylated RLC in human, mouse, and apex could also explain why the apex is not hypertro-
rabbit cardiac and skeletal muscle. The studies on skele- phied in hearts of patients with mutations in either light
tal muscle from these three species serve as a control chain. That is, the normally hyperphosphorylated apex
for our studies of RLC phosphorylation in the heart. has a diminished stretch activation response and the
Beyond the gradient from the outside to the inside of distortion of this response by mutations in either light
the heart, we have also observed a gradient from apex chain is of less consequence to the mechanics of this
to the midcardiac region. Within the regions of high part of the heart.
levels of phosphorylation, we also observe a patchy The utility of the stretch activation response is appar-
pattern of staining that respects fiber boundaries. Thus, ent from observing the action of papillary muscles in
RLC phosphorylation levels of tissue homogenates un- systole (Figure 6A). The papillary muscles tether the inter-
derestimate the high levels and overestimate the low ventricular valves that prevent the backflow of blood
levels of individual fiber RLC phosphorylation. This find- during cardiac systole. In addition, they also support
ing supports the relevance of our studies using fully cardiac torsion by aiding the long-axis shortening of the
phosphorylated slow muscle fibers. heart (Rushmer, 1956). Their surgical compromise leads
to decreased torsion (Moon et al., 1996) and a low output
syndrome (Lillehei et al., 1964). Papillary muscles are
Biophysical and Physiologic Consequences
the first to be innervated but must continue to contract
of RLC Phosphorylation throughout systole. The delayed pulse of tension, initi-
Rabbit slow skeletal muscle fibers express cardiac ated by stretching the activated papillary muscles, is
-myosin. Data obtained from these fibers is thus di- delivered at the end of systole when tension production
rectly relevant to cardiac myosin function, but avoids a by these muscles would otherwise be diminishing. The
number of problems associated with mechanical studies stretch activation response would not be of physiologic
in cardiac muscle preparations. importance if its timing did not match heart rate, but in
RLC phosphorylation causes a very large 2.5-fold in- fact, the rate constant of the stretch activation response
crease in fiber tension from 22% to 56% of the maximal of rabbit slow muscle fibers is commensurate with the
Ca2 activated tension of these slow muscle fibers (J.D. physiologic rate of the rabbit heart (Steiger, 1977; J.D.
et al., submitted). This is one of the largest phosphoryla- et al., submitted). This allows for the stretch-induced
tion-induced tension increases ever recorded. Since the tension to be added to the force of contraction at the
contracting heart functions at, and below, half-maxi- end of systole, much in the same way as a push to a
mum Ca2activation, RLC phosphorylation has the po- swinging object must be applied at the proper time if
tential to modulate cardiac contraction from low ten- oscillatory power is to be increased.
sions to full power at a fixed concentration of Ca2. On the other hand, the dramatic increase in slow mus-
Recent small 0.1% step-stretch L-jump experiments cle fiber tension produced by increased RLC phosphory-
show the consequence that RLC phosphorylation has lation of the epicardial fibers enables the hyperphosph-
on the kinetics of contraction (J.D. et al., submitted). orylated epicardial fibers to dominate the right-handed
These kinetic studies demonstrate that the stretch acti- helical twist of the endocardial fibers during the produc-
vation response (Huxley-Simmons phase 3) is uniquely tion of torsion. It may also be that the shearing forces
affected by RLC phosphorylation. In the large perturba- that must arise from the counterhelicity of the epicardial
tion experiments shown here, phosphorylation-induced and endocardial fibers is minimized by the shape of the
changes in the kinetic amplitudes scale in proportion to stretch activation transient. Because stretching hypo-
the size of the stretch applied to the fiber. In 0.8% step- phosphorylated fibers triggers an exaggerated drop in
tension, the counterhelical force imposed by the hyper-stretch experiments, phosphorylation causes a 41% de-
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phosphorylated epicardial fibers on the hypophosphor- of the myosin neck. Although a sample of two is too
small for statistical significance, our ongoing studies onylated endocardial fibers may produce a reduction in
tension of the endocardial fibers. In this way, the shear individuals with alleles of the MLCK gene should provide
the numbers of individuals needed for such a study.between epicardial and endocardial fibers would be di-
minished, producing a corresponding drop in energy/
oxygen requirements. This model provides a rationale Conclusions
The work presented here is an example of how variationsfor the evolutionary conservation of counterhelically ori-
ented fibers in the endocardium and epicardium of ver- at a molecular level can be projected through cellular orga-
nization to the level of global cardiac function. We have:tebrate hearts. It may also contribute to the faster angu-
lar velocity of the endocardial fibers as they drop their (1) demonstrated a gradient of myosin RLC phosphory-
lation across the heart, (2) identified a kinase contribut-resistance following a stretch (Figure 6B). In this context,
the stretch activation response can also be thought of as ing to the gradient, (3) demonstrated the biophysical
consequences of this phosphorylation, and (4) suggesteda mechanism to return, with an appropriate time delay,
some of the tension that is lost in the hypophosphory- how the gradient of phosphorylation can facilitate an
overall pattern of cardiac contraction viewed with MRIlated papillary muscles and endocardium.
imaging.
The Cloning of a Cardiac MLCK
Experimental ProceduresIf, in fact, RLC phosphorylation has the important car-
diac function presented here, we reasoned that there Subjects
may be cardiomyopathic patients who have developed In vivo MR cardiac scans of normal human subjects were conducted
on a General Electric 1.5 tesla cardiac scanner. Informed consentdisease as the result of an inherited abnormality in the
for the MRI studies and the genetic screening was obtained in accor-responsible kinase. To date, the existence of a striated
dance with study protocols 97-H-0026 and 87-H-57, respectively,myosin RLC kinase in the heart is controversial. Our
approved by the Institutional Review Board of the National Heart,strategy for cloning such a kinase was based on the
Lung, and Blood Institute.
similarity between skeletal and cardiac RLC. The distri-
bution of skeletal/cardiac MLCK in mouse and human Animal Studies
Animal studies were conducted under protocols 8CB3R and 9CB2heart matches the pattern of RLC phosphorylation. This
in accordance with the National Heart, Lung, and Blood Instituteuneven distribution of the MLCK is probably the reason
Animal Care and Use Committee.that others have failed to detect the skeletal muscle
MLCK in heart (Herring et al., 2000), since homogenates
Cloning of the Human Skeletal/Cardiac MLCK
from total heart will contain much less kinase than ho- The rabbit skeletal muscle MLCK cDNA sequence (Herring et al., 1990)
mogenates from the epicardium and apex. was used to design a set of primer pairs to amplify unique RNA frag-
ments from both rabbit skeletal and cardiac muscle. Product from oneIn the mouse and human heart, the antibody raised
pair of primers (upstream 5-TGATCCAGCTGTACGCAGCC-3, down-against this expressed human skeletal/cardiac MLCK
stream 5-CTTGAGGTCCAGGTGCAGC-3) yielded identically sizeddetects two additional larger fragments of 120 kDa and
201 bp fragments from both templates. The degenerate downstream98 kDa, as well as the unique 74 kDa MLCK fragment
primer used to amplify a homologous fragment from human cardiac
seen in human skeletal muscle. Because these addi- RNA was 5-AGGTCCAg/aGTGCAGc/a/t/gACCCg/tCA-3. The up-
tional bands are absent in skeletal muscle, they may stream primer, which is highly conserved in rat and rabbit, was not
made degenerate: (5-CATGAACCAGCTTAACCACCG-3). Theserepresent additional gene products, alternatively spliced
primers yielded a fragment of human genomic DNA containing partsisoforms, or posttranslational modifications of the 74
of exon 6 and 7 separated by an 81 bp intron. In order to obtainkDa fragment. The increased density of the 98 kDa frag-
full-length human genomic sequence, a primer based in human intronment at the apex may cause increased RLC phosphory-
6 (5-CCACGGCTTGCTCCGTGCCT-3) was used together with an up-
lation at that site. stream exon 6 primer (5-ATCGAGACTCCGCATGAGAT-3) to screen
We scanned the DNA of 490 patients with hypertro- a human P1 library (Genome Systems).
In order to obtain a full-length cDNA from human heart, 5- andphic hearts, 189 controls, and 500 patients with coronary
3-RACE was performed using a Marathon RACE kit (Clontech).artery disease for mutations in the coding portion of the
3-RACE was initiated with an exon 7-based primer: 5-TCGAGACTgene. Only a single mutation was found. The Vmax of the
CCGCATGAGAT-3. An approximately 1100 bp fragment was ob-expressed mutant MLCK is double that of expressed
tained. 5-RACE was performed using an exon 6-based primer:
wild-type. Although the Km of the mutant MLCK tripled, 5-ATCTCATGCGGAGTCTCGA-3. Indeterminate product was am-
this change is probably irrelevant since the physiologic plified using a seminested exon 3 primer derived from the genomic
clone and yielded an 850 bp fragment. The seminested primer is:concentration of RLC in muscle is 20-fold greater than
5-TCTGAGGGAACAGCCTGGAAC-3. The gap between the 5- andthe highest Km. The development of compensatory hy-
3-RACE products was bridged by RT-PCR, amplifying from humanpertrophy in the face of a doubling of the Vmax of the
cardiac RNA. Each exon was then subsequently located in the geno-mutant MLCK suggests that a proper balance of RLC
mic P1 clone that had been obtained by selecting with the intron
phosphorylation is required for proper cardiac function. 6-based fragment described above.
Both mother and father have asymmetrically hypertro-
phied ventricles. The son, who has also inherited both MLCK Expression
The whole MLCK cDNA was subcloned into a pVL1393 baculovirushis mother’s mutant MLCK and his father’s mutant
transfer vector (PharMingen) under the polyhedrin promoter with a-myosin heavy chain mutation (E743D), had an early
FLAG-tag at the 5 end of MLCK. The baculovirus-containing MLCKmidcavity type distribution of hypertrophy at age 13.
gene was then constructed with the BaculoGold system (PharMigen)
The increased severity at this young age suggests a from the transfer vector. The MLCK protein was expressed by in-
compound effect. Figure 5A shows that as a result of fecting the virus into the SF9 insect cells and purified using anti-
FLAG affinity agarose resin (Sigma). The purified MLCK was dialyzedhis co-inheritance, he has abnormalities at both ends
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into a buffer containing 10 mM MOPS, 0.5 mM EGTA, 0.2 M NaCl, sion of the left ventricle during the ejection phase in the intact dog.
Cardiovasc. Res. 18, 183–193.1 mM dithiothreitol (DTT), and 10% glycerol, at pH 7.0.
Beyar, R., and Sideman, S. (1986). The dynamic twisting of the left
MLCK Kinetics Assay ventricle: a computer study. Ann. Biomed. Eng. 14, 547–562.
The phosphorylation of myosin RLC was performed in buffer pH 7.2
Bresnick, A.R. (1999). Molecular mechanisms of nonmuscle myosin-
containing 50 mM MOPS, 10 mM Mg acetate, 1 mM DTT, 0.6 mM
II regulation. Curr. Opin. Cell Biol. 11, 26–33.
CaCl2, 2 	 107 M calmodulin, and 0.5 mM ATP (with 32P-labeled
Buchalter, M.B., Weiss, J.L., Rogers, W.J., Zerhouni, E.A., Weisfeldt,ATP, 30 ci mmol1) at 25C. The final MLCK concentration was 28
M.L., Beyar, R., and Shapiro, E.P. (1990). Noninvasive quantificationng ml1. The reaction mixture with RLC but without MLCK was
of left ventricular rotational deformation in normal humans usingpreincubated at 25C for 10 min. The reaction phosphorylation was
magnetic resonance imaging myocardial tagging. Circulation 81,initiated by the addition of MLCK. Twenty l aliquots of the reaction
1236–1244.mixture were spotted onto Whatman #3 filter paper, and the reaction
Callaghan. P.T. (1991). Principles of Nuclear Magnetic Resonancewas stopped by immersing the filter paper in a solution of 10% TCA
Microscopy, First Edition (Oxford: Clarendon Press).and 8% sodium pyrophosphate at 4C. The filter paper was then
rinsed three times in a 10% TCA and 2% sodium pyrophosphate Craig, R., Padron, R., and Kendrick, J.J. (1987). Structural changes
solution, once in ethanol, and three times in ether before being air accompanying phosphorylation of tarantula muscle myosin fila-
dried. The concentration of phosphorylated RLC labeled with 32P ments. J. Cell Biol. 105, 1319–1327.
on the filter paper was determined in a scintillation counter.
Cuda, G., Fananapazir, L., Zhu, W.S., Sellers, J.R., and Epstein, N.D.
(1993). Skeletal muscle expression and abnormal function of beta-
Myosin Light Chains Complex Expression myosin in hypertrophic cardiomyopathy. J. Clin. Invest. 91, 2861–
Human -myosin binding domain for the myosin light chains (aa 2865.
778–840) was subcloned into a pVL1393 baculovirus transfer vector
Davis, J.S. (2000). Kinetic analysis of dynamics of muscle function.under the polyhedrin promoter with a FLAG-tag at its 3 end. Myosin
Methods Enzymol. 321, 23–37.ELC and RLC cDNA sequences were also subcloned into pVL1393
Greenbaum, R.A., Ho, S.Y., Gibson, D.G., Becker, A.E., and Ander-transfer vectors. All three proteins were expressed simultaneously
son, R.H. (1981). Left ventricular fibre architecture in man. Br. Heartin the baculovirus system by infecting SF9 insect cells with the
J. 45, 248–263.viruses. Expressed myosin ELC and RLC and the myosin heavy
chain binding domain formed a complex that was purified on an Herring, B.P., Stull, J.T., and Gallagher, P.J. (1990). Domain charac-
anti-FLAG affinity agarose resin (Sigma). terization of rabbit skeletal muscle myosin light chain kinase. J. Biol.
Chem. 265, 1724–1730.
Production of MLCK Antibody Herring, B.P., Dixon, S., and Gallagher, P.J. (2000). Smooth muscle
Rabbits were inoculated with the FLAG-tag affinity-purified MLCK myosin light chain kinase expression in cardiac and skeletal muscle.
protein and boosted at 2, 4, and 6 weeks. The 8- and 10-week sera Am. J. Physiol. Cell Physiol. 279, C1656–1664.
were affinity purified against the full-length MLCK protein by column
Lankford, E.B., Epstein, N.D., Fananapazir, L., and Sweeney, H.L.chromatography.
(1995). Abnormal contractile properties of muscle fibers expressing
beta-myosin heavy chain gene mutations in patients with hypertro-L-Jump Experiments
phic cardiomyopathy. J. Clin. Invest. 95, 1409–1414.Experimental details and methods of analysis are described in detail
Levine, R.J., Yang, Z., Epstein, N.D., Fananapazir, L., Stull, J.T.,elsewhere (Davis, 2000; J.D. et al., submitted).
and Sweeney, H.L. (1998). Structural and functional responses of
mammalian thick filaments to alterations in myosin regulatory lightRLC Phosphorylation Assay
chains. J. Struct. Biol. 122, 149–161.Single fiber segments were assayed to determine the level of RLC
phosphorylation by selective extraction of the light chain (Craig et Lillehei, C.W., Levy, M.J., and Bonnabeau, R.C. (1964). Mitral valve
al., 1987) followed by separation of the RLC species by glycerol- replacement with preservation of papillary muscles and chordae
PAGE (Perrie and Perry, 1970). The gels were silver-stained and tendineae. J. Thorac. Cardiovasc. Surg. 47, 532–543.
scanned for quantitation. Maier, S.E., Fischer, S.E., McKinnon, G.C., Hess, O.M., Krayenbuehl,
H.P., and Boesiger, P. (1992). Evaluation of left ventricular segmental
Enzyme Kinetics wall motion in hypertrophic cardiomyopathy with myocardial tag-
Steady-state kinetic parameters for the mutant and normal myosin ging. Circulation 86, 1919–1928.
light chain kinases were determined by using the nonlinear form of
Moon, M.R., DeAnda, A., Daughters, G.T., Ingels, N.B., and Miller,the Michaelis-Menten equation to fit Km and Vmax values to initial rate D.C. (1996). Effects of chordal disruption on regional left ventriculardata using the nonlinear least squares fitting routine of the program
torsional deformation. Circulation 94, II143–151.Kaleidagraph (Synergy Software; Reading, PA).
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Accession Numbers
The gene for human skeletal/cardiac MLCK has been designated
MYLK2. The complete coding sequence for the 596 amino acid resi-
dues has been deposited at GenBank (accession number AF325549)
(see Experimental Procedures section for details of cloning).
